The ACSL A/G polymorphism is associated with endurance trainability. Previous studies have demonstrated that homozygotes of the minor AA allele had a reduced maximal oxygen consumption response to training compared to the common GG allele homozygotes, and that the ACSL A/G single nucleotide polymorphism explained 6.1% of the variance in the VO2max response to endurance training. The contribution of ACSL single nucleotide polymorphism to endurance trainability was shown in nonathletes, however, its potential role in professional athletes is not clear. Moreover, the genetic basis to anaerobic trainability is even less studied. Therefore, the aim of the present study was to examine the prevalence of ACSL single nucleotide polymorphism among professional Israeli long distance runners (n=59), middle distance runners (n=31), sprinters and jumpers (n=48) and non-athletic controls (n=60). The main finding of the present study was that the ACSL1 AA genotype, previously shown to
be associated with reduced endurance trainability, was not higher among sprinters and jumpers (15%) compared to middle-(16%) and long-distance runners (15%). This suggests that in contrast to previous studies indicating that the ACSL1 single nucleotide polymorphism may influence endurance trainability among non-athletic individuals, the role of this polymorphism among professional athletes is still not clear.
INTRODUCTION
Long-chain-fatty-acid -CoA ligase 1 is an enzyme that in humans is encoded by the ACSL1 gene [12, 13] . ACSL1 exhibits an important potential relevance to the adaptation to regular exercise. ACSL1 contributes most of the acyl-CoA synthetase activity in adipose tissue and is highly expressed also in skeletal muscles and in the heart. ACSL1 encodes for an enzyme that is involved in the partitioning of fatty acids and the control of lipid influx but, even more importantly, the control of carbohydrate efflux [8] . It plays a key role in normal insulin metabolism and fatty acid-induced insulin resistance. A SNP in ACSL1 has been associated with fasting glucose, insulin resistance, and the presence of metabolic syndrome, particularly in the presence of a high-fat diet [10] . Besides its possible relevance to habitual physical activity and exercise, studies have shown that homozygotes of the rs6552828 minor allele (A/A) had 125 ml/min (28%) and 63 ml/min (17%) lower VO2max responses to endurance exercise training than the common allele homozygotes (G/G) and heterozygotes (A/G), respectively. In a single-SNP analyses, rs6552828 explained 6.1% of the variance in the VO2max response to training [3] . Therefore, the potential contributing role of the ACSL1 gene in aerobic metabolism at the adypocite, cardiomyocite, liver and skeletal muscle fiber level [4, 5-7, 9, 11] highlights its potential to explain individual variability in endurance performance, as well as in some health-related phenotypes.
While the contribution of ACSL1 single nucleotide polymorphism to endurance trainability was shown in non-athletes, its potential role in professional athletes is less studied. Moreover, the genetic basis to anaerobic trainability is even less studied. Therefore, the aim of the present study was to examine the prevalence of ACSL1 SNP among professional Israeli long distance runners, middle distance runners, sprinters and jumpers. We hypothesized that the ACSL1 AA genotype associated with reduced endurance trainability would be higher among sprinters and jumpers.
MATERIALS AND METHODS

Subjects
One hundred and thirty-eight male athletes [59 long distance runners (LDR), 31 middle distance runners (MDR), 48 sprinters and jumpers (S/J)], and 60 non-athletic controls participated in the study. All athletes competed in national and/or international level meets on a regular basis. Athletes' data are presented in Table 1 . LDR -long distance runners; MDR -middle distance runners; S/J -sprinters and jumpers
The study was approved by the Institutional Review Board of the Hillel Yaffe Medical Center, Hadera, Israel, according to the Declaration of Helsinki. A written informed consent was obtained from all participants.
Genotyping
Genomic DNA was extracted from samples of peripheral venous blood or buccal cells according to the salting-out procedure. Genotypes were determined using the Taqman allelic discrimination assay. The Assay-by-Design service (https://www.thermofisher.com /il/en/home.html) was used to set up a Taqman allelic discrimination assay for the ACSL (rs6552828 A/G), Primers and probe sequences are given in Table 2 . 
RESULTS
The complete data on allele and genotype frequencies are presented in Table 3 . The genotype subtype did not differ by age or sex. ACSL genotypes were in agreement with the Hardy-Weinberg equilibrium for all groups (p = 0.917 for Controls, p = 0.843 for S/J, p = 0.856 for MDR; p = 0.930 for LDR). The frequency of the ACSL AA genotype carriers, which is related to reduced VO2max response to training, was not significantly different among LDR, MDR, S/J and controls ( Figure 1 ). 
DISCUSSION
The present study examined the prevalence of ACSL1 SNP among professional Israeli long distance runners, middle distance runners, sprinters and jumpers. The main finding of the study was that in contrast to our hypothesis, the ACSL1 AA genotype, previously shown to be associated with reduced endurance trainability, was not higher among sprinters and jumpers compared to long-distance runners.
The ACSL A/G polymorphism is associated with endurance trainability. It was previously demonstrated that homozygotes of the minor AA allele had a reduced VO2max response to training compared to the common GG allele homozygotes, and that the ACSL A/G single nucleotide poly morphism explained 6.1% of the variance in the VO2max response to endurance training [3] . However, while this association was found in non-athletic individuals, the linkage between the ACSL1 single nucleotide polymorphism and endurance trainability among professional athletes, and in particularly, among a homogeneous group of long-distance runners, is much less clear.
The ACSL SNP may vary among different populations of long-distance runners. Consistent with that the frequency of the AA genotype (associated with reduced endurance trainability) among native Israeli long-distance runners was higher (24%) than the frequencies reported among Spanish endurance athletes (17.1%) and lower compared to Chinese (31.3%) endurance athletes [14] . Moreover, we recently studied the frequency of the ACSL genotype among Israeli long-distance runners of Ethiopian and nonEthiopian origin. The Ethiopian Beta Israel community consist only about 1.7% of the overall Israeli population, but their dominance in Israeli longdistance record table is dramatic (e.g. between 50-66% of the 30 all-time best male results in the marathon and half-marathon). We found that the frequency of the AA genotype carriers among Israeli long-distance runners of Ethiopian origin was significantly lower (8%) compared to the nonEthiopian Origin Israeli runners (24%) [2] . Thus, fewer long-distance runners of Ethiopian origin had a genetic predisposition for reduced response to aerobic training. Interestingly, among the non-Ethiopian origin runners the frequency of AA carriers was significantly lower among elite compared to national levels runners suggesting the potential role of the ACSL genotype for endurance excellence in this population as well.
We hypothesized that since endurance trainability is less important for short-distances athletic events, the frequency of the ACSL1 single nucleotide polymorphism would be lower among sprinters and jumpers. However, in contrast to our hypothesis no significant difference was found in the ACSL AA genotype between professional Israeli long-distance runners, middledistance runners, sprinters and jumpers. The potential contribution of many potential genes for excellence in endurance and anaerobic-power type sports were studied in recent years, and several favoring endurance and anaero bicpower single nucleotide polymorphism profiles were proposed [1] . The present study suggests that the ACSL1 single nucleotide polymorphism cannot distinguish between these two ends of the endurance to sprint
The potential use of genetic polymorphisms, and in particular the single nucleotide polymorphism (SNP) of hormone genes, as a tool to assist in predicting future athletic performance is currently an extremely challenging topic, mainly because each possible gene makes only a small contribution to the overall heritability. Previous results and the results of the present study suggest that while the ACSL1 single nucleotide polymorphism may influence endurance trainability among non-athletic individuals, its role among professional athletes is still not clear.
